Application Note

Distributed Biobanking: An End To End Solution For FFPE Tissue Block Management

Source: Thermo Fisher Scientific

By Suman Verma

Distributed Biobanking

From a historical perspective, there are millions of FFPE tissue blocks in storage and in use today; these range in age from being generated several decades ago to blocks prepared at the time of this writing.  Block storage methodologies have typically been comprised of the following, although there are variations on the theme:

  1. Each FFPE Block is identified by applying handwritten or printed labels to the block/cassette based on patient information. 
  2. Blocks are sorted numerically. As blocks from additional tissues for the same patient are generated at a later time, grouped blocks are re-sorted to accommodate the nested blocks.
  3. Blocks are archived on-site for a length of time until storage space becomes an issue.
  4. Blocks are routinely retrieved when slides need to be made. Delays in returning these blocks to the archive can cause blocks to be placed in the wrong location, resulting in delays when trying to locate blocks in this situation. Often, the entire archive needs to be searched manually to locate the missing block.
  5. Blocks are stored off-site after on-site storage capacity is exceeded, using the same numerical storage method. 

This storage process works well for small numbers of samples, but is quickly overrun when thousands of blocks begin to accumulate. The retrieval and return process can be error prone, leading to potential specimen loss, delays in retrieval, and excessive time spent re-cataloging and locating blocks, all translating to patient impacting events.  Given today’s patient health care requirements, many FFPE blocks need to be retrieved daily; with the legacy systems described above, biospecimens are not always archived on the same day. Coupled with the constant demand for block retrieval there are cases in which sporadic, manual record keeping is maintained of who a block was sent to or when a block is due to return.  In addition, many blocks sent out for clinical trial use can lack traceability for the same reasons.

Recently, an end to end system (Arcos™ Block Management System, Thermo Fisher Scientific Kalamazoo, MI) was developed and implemented in several locations worldwide to address the issues encountered with FFPE block storage, retrieval and restocking.  The Arcos system is primarily designed to accurately store, catalog and track FFPE blocks, minimizing/eliminating potential patient impacting events caused by delayed FFPE retrieval and re-archiving events, is 21 CFR Part 11 compliant and eliminates the need to catalog blocks in numerical or similar order.